AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18637106 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal spectacles with 'head neutral-gaze forward'
Number of subjects: 18
Study 16706261 — intervention group
Group type: EXPERIMENTAL
Intervention: Pen-and-paper coronary risk estimator
Number of subjects: 535
Study 15263050 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants and psychotherapy
Number of subjects: 0
Study 15263050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11673101 — intervention group
Group type: EXPERIMENTAL
Intervention: CDSS in psychiatry
Number of subjects: 0
Study 11673101 — intervention group
Group type: EXPERIMENTAL
Intervention: CDSS
Number of subjects: 0
Study 11673101 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 9144118 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard glucose-based ORS in alternation with soy-based, lactose-free infant formula (Group 1)
Number of subjects: 0
Study 9144118 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice syrup solid containing ORS in alternation with rice-based, lactose-free infant formula (Group 2)
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using sumatriptan
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using MK‐462
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using 311C90
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using dihydroergotamine
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using nonsteroidal anti‐inflammatory drugs
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using butorphanol
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using metoclopramide
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute drug therapy using domperidone
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic drug therapy using valproate
Number of subjects: 0
Study 8081520 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic drug therapy using fluoxetine
Number of subjects: 0
Study 31948301 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal chiropractic manipulative therapy (SCMT)
Number of subjects: 100
Study 31948301 — intervention group
Group type: COMPARATOR
Intervention: Standard AMS pain control
Number of subjects: 100
Study 31948301 — intervention group
Group type: EXPERIMENTAL
Intervention: SCMT
Number of subjects: 100
Study 30304077 — intervention group
Group type: COMPARATOR
Intervention: Control group (only sutures applied)
Number of subjects: 50
Study 30304077 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate group
Number of subjects: 50
Study 30304077 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal dressing material group
Number of subjects: 50
Study 30304077 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic gelatin sponge group
Number of subjects: 50
Study 30304077 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin sponge combined with cyanoacrylate group
Number of subjects: 50
Study 27053407 — intervention group
Group type: EXPERIMENTAL
Intervention: ARB + CCB
Number of subjects: 168
Study 27053407 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI + CCB
Number of subjects: 168
Study 27053407 — intervention group
Group type: COMPARATOR
Intervention: beta-blocker + diuretic
Number of subjects: 168
Study 27053407 — intervention group
Group type: COMPARATOR
Intervention: ACEI + diuretic
Number of subjects: 168
Study 27053407 — intervention group
Group type: COMPARATOR
Intervention: angiotensin II receptor blocker (ARB) + diuretic
Number of subjects: 168
Study 26859013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive FP counselling
Number of subjects: 127
Study 26859013 — intervention group
Group type: COMPARATOR
Intervention: Routine FP counselling
Number of subjects: 127
Study 26859013 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-placental IUCD
Number of subjects: 127
Study 22857944 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task condition (cognitive task during gait)
Number of subjects: 59
Study 22857944 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive task during gait)
Number of subjects: 59
Study 20676545 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator sling surgery
Number of subjects: 30
Study 20676545 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic sling surgery
Number of subjects: 30
Study 18706007 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined i.v./i.a. approach to recanalization (lower dose of i.v. rt-PA approximately 0.6 mg/kg, 60 mg maximum over 40 min, followed by angiography and possible i.a. therapy)
Number of subjects: 900
Study 18706007 — intervention group
Group type: COMPARATOR
Intervention: Standard i.v. rt-PA alone (full dose 0.9 mg/kg, 90 mg maximum over 1 hour)
Number of subjects: 900
Study 18706007 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined i.v./i.a. approach to recanalization
Number of subjects: 900
Study 18706007 — intervention group
Group type: COMPARATOR
Intervention: Standard i.v. rt-PA alone
Number of subjects: 900
Study 17261975 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinstitution or continuation of GH therapy
Number of subjects: 0
Study 17261975 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing GH therapy
Number of subjects: 0
Study 17261975 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of childhood GH replacement therapy without restart in adults
Number of subjects: 0
Study 12663289 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGHNAT-E formula (20 IU RRR-alpha-tocopheryl acetate/L, 14.5 mg/L)
Number of subjects: 77
Study 12663289 — intervention group
Group type: EXPERIMENTAL
Intervention: LOWNAT-E formula (10 IU RRR-alpha-tocopheryl acetate/L, 7.3 mg/L)
Number of subjects: 77
Study 12663289 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN-E formula (13.5 IU synthetic all-rac-alpha-tocopheryl acetate/L, 13.5 mg/L)
Number of subjects: 77
Study 12663289 — intervention group
Group type: COMPARATOR
Intervention: Human milk-fed group (n = 29)
Number of subjects: 77
Study 10809343 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral suspension (200 mg phenytoin)
Number of subjects: 6
Study 10809343 — intervention group
Group type: COMPARATOR
Intervention: Rectal suppository (200 mg phenytoin)
Number of subjects: 6
Study 8841210 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 50 micrograms per vagina every 4 hours as needed
Number of subjects: 222
Study 8841210 — intervention group
Group type: COMPARATOR
Intervention: Standard approach (physician‐chosen combinations of intracervical or vaginal dinoprostone every 6 hours, artificial rupture of membranes, and oxytocin infusion)
Number of subjects: 222
Study 8841210 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 222
Study 1338088 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg SPFX
Number of subjects: 91
Study 1338088 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg SPFX
Number of subjects: 91
Study 6229975 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 241
Study 6229975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study 28627220 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory bifactor model for the PSS
Number of subjects: 11939
Study 28627220 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory bifactor model for the PSS
Number of subjects: 11939
Study 28627220 — intervention group
Group type: EXPERIMENTAL
Intervention: PSS factors analysis
Number of subjects: 11939
Study 29902542 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical spray treatment with 0.005% rhEGF
Number of subjects: 167
Study 29902542 — intervention group
Group type: COMPARATOR
Intervention: Saline spray (placebo)
Number of subjects: 167
Study 27085389 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 750
Study 27085389 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 750
Study 27085389 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 750
Study 27085389 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 750
Study 24838790 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab treatment
Number of subjects: 108
Study 22750962 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal splint
Number of subjects: 39
Study 22750962 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar splint
Number of subjects: 39
Study 22750962 — intervention group
Group type: COMPARATOR
Intervention: No splint (control group)
Number of subjects: 39
Study 19446145 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg
Number of subjects: 150
Study 19446145 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 150
Study 19446145 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg with tourniquet
Number of subjects: 150
Study 19446145 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet control (saline)
Number of subjects: 150
Study 19446145 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed flurbiprofen axetil 50 mg and propofol
Number of subjects: 150
Study 19446145 — intervention group
Group type: COMPARATOR
Intervention: Mixed control (saline and propofol)
Number of subjects: 150
Study 17082176 — intervention group
Group type: EXPERIMENTAL
Intervention: NQO1 609*T allele
Number of subjects: 1840
Study 17082176 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers with heterozygous variant genotype
Number of subjects: 1840
Study 17082176 — intervention group
Group type: EXPERIMENTAL
Intervention: Common C/C genotype with alcohol consumption
Number of subjects: 1840
Study 17082176 — intervention group
Group type: COMPARATOR
Intervention: mEH3 and mEH4 variants
Number of subjects: 1840
Study 15746294 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 53
Study 15746294 — intervention group
Group type: COMPARATOR
Intervention: Strength Training (ST)
Number of subjects: 53
Study 11802925 — intervention group
Group type: EXPERIMENTAL
Intervention: QuickVue® chlamydia test for high prevalence population
Number of subjects: 0
Study 11802925 — intervention group
Group type: EXPERIMENTAL
Intervention: QuickVue® chlamydia test for low prevalence population
Number of subjects: 0
Study 11802925 — intervention group
Group type: EXPERIMENTAL
Intervention: QuickVue® chlamydia test for both populations
Number of subjects: 0
Study 11802925 — intervention group
Group type: COMPARATOR
Intervention: Laboratory‐based immunoassay techniques
Number of subjects: 0
Study 9791638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (screening)
Number of subjects: 9780
Study 9791638 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-screening)
Number of subjects: 9780
Study 7808885 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinted nonoptical (Irlen) lenses
Number of subjects: 60
Study 7808885 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 2627821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine alone
Number of subjects: 53
Study 2627821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine plus antacid (aluminum hydroxide gel)
Number of subjects: 53
Study 180938 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with carmustine (80 mg/sq m/day for three days) and vincristine sulfate (1.4 mg/sq m on days 1 and 8)
Number of subjects: 33
Study 180938 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (4,500 rads whole brain plus 1,500 rads to the side of the tumor)
Number of subjects: 33
Study 30624012 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume tidal peritoneal dialysis (TPD)
Number of subjects: 49
Study 30624012 — intervention group
Group type: COMPARATOR
Intervention: Low-volume intermittent peritoneal dialysis (IPD)
Number of subjects: 49
Study 28246236 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 3808
Study 28246236 — intervention group
Group type: COMPARATOR
Intervention: hsTnI ≥99th percentile upper reference limit at 6 months
Number of subjects: 3808
Study 28246236 — intervention group
Group type: COMPARATOR
Intervention: Persistently elevated hsTnI
Number of subjects: 3808
Study 28246236 — intervention group
Group type: COMPARATOR
Intervention: Undetectable hsTnI at baseline and 6 months
Number of subjects: 3808
Study 24573974 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM)
Number of subjects: 6
Study 24573974 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue grafts (sCTG)
Number of subjects: 6
Study 23347535 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO) 15 mL/day for 6 weeks
Number of subjects: 37
Study 23347535 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (OO) 15 mL/day for 6 weeks
Number of subjects: 37
Study 23347535 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO) 15 mL/day
Number of subjects: 37
Study 21872376 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulodexide 200 mg/d
Number of subjects: 1056
Study 21872376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1056
Study 19805398 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional prevention programme combining physical training, patient transfer technique and stress management
Number of subjects: 766
Study 19805398 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 766
Study 19805398 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional prevention programme
Number of subjects: 766
Study 17409802 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 every 3 weeks
Number of subjects: 111
Study 17409802 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel 30 mg/m2 on days 1, 8, and 15 every 28 days
Number of subjects: 111
Study 17409802 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel weekly (30 mg/m2)
Number of subjects: 111
Study 17409802 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PS 0-1
Number of subjects: 111
Study 15165646 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary palliative care clinic (MD clinic)
Number of subjects: 138
Study 15165646 — intervention group
Group type: COMPARATOR
Intervention: Traditional pain and symptom management clinic (PSM clinic)
Number of subjects: 138
Study 11461753 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate
Number of subjects: 46
Study 11461753 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 46
Study 11461753 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 46
Study 9527193 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose epsilon-aminocaproic acid (10 g loading and priming dose, 2.5 g/h until 4 hours after protamine)
Number of subjects: 20
Study 9527193 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (2 x 10(6) KIU for loading and priming, 0.5 x 10(6) KIU/h)
Number of subjects: 20
Study 9527193 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 untreated patients)
Number of subjects: 20
Study 7993957 — intervention group
Group type: EXPERIMENTAL
Intervention: BRL 46470 (1 mg orally)
Number of subjects: 12
Study 7993957 — intervention group
Group type: COMPARATOR
Intervention: mCPP (0.08 mg/kg over 2 min)
Number of subjects: 12
Study 2597634 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% ointment
Number of subjects: 6
Study 2597634 — intervention group
Group type: COMPARATOR
Intervention: Base treated sites (control)
Number of subjects: 6
Study 30099 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg diazepam, t.i.d.
Number of subjects: 40
Study 30099 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg chlordiazepoxide, t.i.d.
Number of subjects: 40
Study 30099 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol, 5g/kg
Number of subjects: 40
Study 30099 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 40
Study 30099 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment perception
Number of subjects: 40
Study 31001740 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 52
Study 31001740 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong
Number of subjects: 52
Study 30260895 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 223
Study 30260895 — intervention group
Group type: COMPARATOR
Intervention: External palpation
Number of subjects: 223
Study 27142579 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% Sodium Hypochlorite (NaOCl)
Number of subjects: 50
Study 27142579 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Chlorhexidine (CHX)
Number of subjects: 50
Study 24609887 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1ra (100 mg for 4 weeks)
Number of subjects: 22
Study 24609887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 22327920 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional angioplasty
Number of subjects: 48
Study 22327920 — intervention group
Group type: COMPARATOR
Intervention: Cryoplasty
Number of subjects: 48
Study 20164847 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg/day) + Olmesartan medoxomil (40 mg/day)
Number of subjects: 0
Study 20164847 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (10 mg/day)
Number of subjects: 0
Study 20164847 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan medoxomil (40 mg/day)
Number of subjects: 0
Study 20164847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18058482 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of thioctic acid (ALA) 600 mg
Number of subjects: 0
Study 18058482 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of thioctic acid
Number of subjects: 0
Study 16075942 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (water treatment device with filter and UV light)
Number of subjects: 50
Study 16075942 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (no treatment device)
Number of subjects: 50
Study 12126819 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 999
Study 12126819 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity oral anticoagulation
Number of subjects: 999
Study 12126819 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined low-dose aspirin and moderate intensity oral anticoagulation
Number of subjects: 999
Study 10567756 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful leading leg's tibialis anterior muscle
Number of subjects: 6
Study 8712395 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg intravenous (IV) bolus alfentanil
Number of subjects: 25
Study 8712395 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms/kg intravenous (IV) bolus alfentanil
Number of subjects: 25
Study 8712395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 1789687 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (synthetic analogue of somatostatin) administered intravenously under double-blind, placebo-controlled conditions.
Number of subjects: 14
Study 1789687 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide coadministered with physostigmine to 1 patient.
Number of subjects: 14
Study 1789687 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide infusion in 6 patients.
Number of subjects: 14
Study 7044528 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen-aminoglutethimide-danazol-hydrocortisone (TAD)
Number of subjects: 107
Study 7044528 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 107
Study 31286476 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal sufentanil (5 µg)
Number of subjects: 80
Study 31286476 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (20 µg)
Number of subjects: 80
Study 31286476 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal fentanyl (20 µg)
Number of subjects: 80
Study 31286476 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 µg)
Number of subjects: 80
Study 28341522 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo intervention with specific memories and lesser negative expectations regarding itch
Number of subjects: 0
Study 28341522 — intervention group
Group type: COMPARATOR
Intervention: Nocebo responders
Number of subjects: 0
Study 26631330 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial cellulose graft (BC)
Number of subjects: 40
Study 26631330 — intervention group
Group type: COMPARATOR
Intervention: Autologous temporal fascia (fascia)
Number of subjects: 40
Study 25345446 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately intense physical activity (PA) intervention increased from 60 minutes/week to 40 minutes/school day for 3 years
Number of subjects: 223
Study 25345446 — intervention group
Group type: COMPARATOR
Intervention: Control group continued with 60 minutes/week of physical activity for 3 years
Number of subjects: 223
Study 22843280 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 388
Study 22843280 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg
Number of subjects: 388
Study 22843280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study 20598302 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 113
Study 20598302 — intervention group
Group type: COMPARATOR
Intervention: Sham (untreated control)
Number of subjects: 113
Study 20598302 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RFA and sham
Number of subjects: 113
Study 18047876 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance Outcome Measure for Elder Rehabilitation (BOOMER)
Number of subjects: 1769
Study 18047876 — intervention group
Group type: COMPARATOR
Intervention: Comparison to Modified Elderly Mobility Scale (MEMS)
Number of subjects: 1769